CEFTAP SB

This brand name is authorized in Nigeria.

Active ingredients

The drug CEFTAP SB contains a combination of these active pharmaceutical ingredients (APIs):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone
2	Sulbactam UNII DKQ4T82YE6 - SULBACTAM SODIUM
	Read more about Sulbactam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-0327	Powder for injection	Ceftap SB Injection INJ_PWD 1000 mg; 500 mg	Powder for Solution for Injection in a vial Each vial contains: Sterile Ceftriaxone Sodium USP equiv. to Ceftriaxone 1000 mg, Sterile Sulbactam Sodium USP equiv. to Sulbactam 500 mg	20/12/2019

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD63		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD63

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-0327